Krug, David
Hecht, Markus
Ebert, Nadja
Mäurer, Matthias
Fleischmann, Daniel F.
Fokas, Emmanouil
Straube, Christoph
Nicolay, Nils Henrik
Hörner-Rieber, Juliane
Schmitt, Daniela
von Neubeck, Cläre
Zamboglou, Constantinos
Sperk, Elena
Kaul, David
Hess, Julia
Corradini, Stefanie
Seidel, Clemens
Gani, Cihan
Baues, Christian
Frey, Benjamin
Blanck, Oliver
Gauer, Tobias
Niyazi, Maximilian https://orcid.org/0000-0002-7711-9486
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Received: 4 June 2021
Accepted: 9 August 2021
First Online: 13 September 2021
Change Date: 3 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00066-021-01869-z
Conflict of interest
: D. Krug has received honoraria from Merck Sharp & Dome, outside of the submitted work. J. Hörner-Rieber received speaker fees and travel reimbursement from ViewRay Inc. as well as travel reimbursement from IntraOP Medical and Elekta Instrument AB and a grant from IntraOP Medical outside the submitted work. E. Sperk has received honoraria and travel support from Carl Zeiss Meditec AG, outside the submitted work. C. Seidel has received honoraria for lectures, consultation, or advisory board participation from the following for-profit companies: AbbVie, Bristol-Myers Squibb, HRA Pharma, medac, Roche, outside of the submitted work. C. Gani has received travel fees from Elekta. The Department of Radiation Oncology Tübingen receives financial and technical support from Elekta and Philips. C. Baues has received honoraria from Bristol Myers Squibb, outside of this submitted work. M. Hecht, N. Ebert, M. Mäurer, D.F. Fleischmann, E. Fokas, C. Straube, N.H. Nicolay, D. Schmitt, C. von Neubeck, C. Zamboglou, D. Kaul, J. Hess, S. Corradini, B. Frey, O. Blanck, T. Gauer, and M. Niyazi declare that they have no competing interests.